The Good Pain Management （GPM） Ward Program in China and its impact on Chinese cancer patients： the SYSUCC experience

To improve cancer pain management, trle MeCllCal uncology uepartmem of sun yat-sen University Cancer Center （SYSUCC） launched the Good Pain Management （GPM） Ward Program, which has been recognized by the Chinese Ministry of Health and promoted throughout the nation. This retrospective casecontrol study was designed to evaluate the effectiveness of the program. Patients diagnosed with malignant solid tumors with bone metastasis were eligible. Patients who were admitted 6 months before the initiation of the GPM program were used as the control group, and patients admitted 6 months after the initiation of the program were used as the GPM group. The painreporting rate and pain management index （PMI） were calculated. The pain levels before and after pain management were compared. A total of 475 patients （244 in the control group and 231 in the GPM group） were analyzed. The painreporting rate of the GPM group was significantly higher than that of the control group （62.8% vs. 37.7%, P 〈 0.001）. The PMI of the GPM group was significantly higher than that of the control group （0.083 vs. -0.261, P 〈 0.001）. Therefore, the GPM Ward Program improved the pain management of cancer patients and provided experience for improving cancer pain management in the future.